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The correlation of the differential expression of S100A4 gene 
(mts1) with the differentiation and metastasis of lung cancer
Su, Lei Zhi, Xiuyi Xu, Qingsheng Liu, Baodong Zhang, Yi Wang, 
Ruotian Hu, Mu Liu, Lei Qian, Kun 
Department of Thoracic Surgery, Xuan Wu Hospital of Capital Univer-
sity of Medical Science, Beijing, China
Background: Invasion and metastasis are hallmarks of lung cancer and 
other malignant tumors. The activation of many genes has been shown 
to be important in tumor progression. We studied the corelationship of 
S100A4 gene (mts1) expression with the prognosis evaluation of lung 
cancer. 
Methods: Total RNAs were extracted from 46 cases of patient with 
lung cancer, and 4 lung cancer cell lines (A549, GLC-82, NCI-H446, 
NCI-H460), S100A4 gene expressions were detected at mRNA level by 
reverse transcription-polymerase chain reaction (RT-PCR). 
Results: Up-regulation of S100A4 gene was shown in 29 of 46 
(63.0%) lung cancer patients and all of the lung cancer cell lines, es-
pecially in younger patients( 89.5% vs 44.4%, p <0.01 ), poor differ-
entiated lung cancer patients (81.0% vs 48.0%, p <0.05), mediastinum 
lymphonodus metastasis (77.3% vs 20%, p <0.05) and the IIIa stage 
patients (73.1% vs 0, p <0.05). 
Conclusions: S100A4 gene played an important role in lung cancer 
progression, correlated well with the condition of the lung cancer dif-
ferrentiation, mediastinum lymphonodus metastasis, and the prognosis 
for the patients of lung cancer. It was likely that S100A4 gene as a 
prognostic, predictive, or even diagnostic factor in clinical practice. 
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Construction of antisence Slp2 gene and It’s effects on growthand 
proliferation of lung cancer cell lines
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Background: To study the effects of antisence Slp2 gene on the growth 
and proliferation in lung cancer cell lines. 
Methods: Total RNAs were extracted from 4 lung cancer cell lines 
(A549, GLC-82, NCI-H446, NCI-H460), Slp2 gene expressions were 
detected at mRNA level by reverse transcription-polymerase chain 
reaction (RT-PCR); antisence Slp2 gene plasmid was constructed, and 
transfected into A549, GLC-82, NCI-H446, NCI-H460 cells with lipo-
fectinmin. The expressions of Slp2 gene were analyzed by RT-PCR in 
cloned cells and the non transfected cells: Flow cytometry, MTT assay 
and Soft agar culture was investigated into the effects of antisence Slp2 
gene transfection on DNA content changes in cell cycle, proliferation 
and colony formation ability.
Results: Slp2 gene was positive expressed in A549, GLC-82, NCI-
H446, NCI-H460 cell lines; The ﬂow cytometry experiments presented 
here showed the transfected cells accumulation in the G2-phase of the 
cell cycle; The proliferation of GLC-82, NCI-H446, NCI-H460 cells 
were inhibited by antisence Slp2 gene conspicuously; Dramatic inhibi-
tion of colony formation in soft agar was observed in those transfected 
lung cancer cell lines. 
Conclusions: Our results suggested that Slp2 gene might be a key gene 
in lung cancer cell growth and proliferation. 
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Comparison of genomic alterations by array comparative genomic 
hybridization and RT-PCR in early-relapse and non-relapse non-
small cell lung carcinoma patients
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Lung cancer is the most common cause of cancer mortality in the 
worldwide. Array Comparative Genomic Hybridization (CGH) is a 
recently introduced technology that measures variations in the gene 
copy number of hundreds of genes in a single experiment. It enables 
one to carry out genome-wide screening for regions of genetic altera-
tions, such as chromosome gains and losses, or localized ampliﬁcations 
and deletions.
In this study, we have utilized the array CGH to elucidate the difference 
of the genome-wide alterations between early relapse and non-relapse 
Non-small cell lung carcinoma (NSCLC) patients after surgical resec-
tion. A total of 49 frozen tissues provided from the Korea Lung Tissue 
Bank were used in this study. Twenty ﬁve patients had distant relapse 
within 2 years of resection (Early-relapse group) and 24 patients were 
alive without disease at least 2 years after treatment (Non-relapse 
group). Genomic alterations were analyzed using 1,440 BAC clones in 
the chromosomes and differences between 2 groups were noted in 126 
clones. 
The different DNA copy number variations observed in the between 
Non-relapse and Early-relapse groups were noted on chromosomes 
1p36, 1q41, 3q26, 5q35, 7p15, 8q24, 8p22, 17p11, 18q21, 19p13 and 
20p12.
To conﬁrm the array CGH results, RNA expression level of gene locat-
ed in each was evaluated by RT PCR in tumor samples. With RT-PCR 
of TP73, TGFB2, SNO, MYC and DCC genes, a positive correlation 
was found between gene copy number variation (aCGH) and mRNA 
expression (RT-PCR).
We will further try to identify high relapse risk group using more tumor 
tissues and to identify prognosis related genes. And, we will consider 
the various platforms that used logistic analysis.
This study on deﬁning the gene involved in Early-relapse may thus be 
of value in understanding the prognosis of NSCLC after surgical resec-
tion. 
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